KX-826 , a small change in the pipeline
    Research/Science 2/10/2026

    At a glance
    In this research discussion post, the primary subjects mentioned are
    πŸ’§ KX-826 (topical) 0.5% and 1.0% BID
    πŸ’§ Clascoterone (topical)
    πŸ’§ Minoxidil (topical) 5% 2x daily 5 weeks
    πŸ’§ Dermarolling (topical) 1x weekly
    the tone is 😐 neutral with modest improvements results.

    Other terms

    KX-826 is undergoing trials for hair loss treatment, showing similar effectiveness between 0.5% and 1.0% dosages, with mild side effects compared to finasteride. Users discuss combining KX-826 with other treatments like minoxidil and clascoterone for better results.
    View this post in the Community β†’

    Similar Community Posts Join

    5 / 370 results

      community Kintor Phase 2 Results released KX-826 (pyrilutamide)

      in Research/Science  444 upvotes 3 years ago
      Kintor Pharmaceutical's Phase 2 results with the drug Pyrilutamide, a potential alternative to 5-ARI drugs like Finasteride and Dutasteride but without the side effects. It could be used in combination with other topical treatments such as Minoxidil. The safety of the drug has been demonstrated in 6 months of use, however there are still questions about long term efficacy and systemic absorption.

      community Keep your heads up bros, don't let balding affect your mental

      in Chat  59 upvotes 3 days ago
      Hair loss can cause psychological distress, but maintaining optimism and self-improvement is crucial. Treatments like minoxidil, finasteride, and potential new options like clascoterone offer hope, though side effects can occur.

      community One year on finasteride has reversed some aging

      in Chat  198 upvotes 4 months ago
      Finasteride and minoxidil use resulted in a more youthful appearance and improved skin. There is debate about their effects on collagen and skin aging, with no solid evidence supporting significant changes due to finasteride.

    Related Research

    6 / 175 results